In the realm of prognosis, high CLDN2 in colorectal cancer, high CLDN6/9 in endometrial cancer, or low CLDN7 in various cancers could inform risk stratification and follow-up intensity. This evidence concerns the gene CLDN6 and colorectal cancer.